Table 2. Association of potential predictors with initial success at 10 weeks controlling for treatment group.
| Failure (N=94) |
Success (N=175) |
P-value * | |
|---|---|---|---|
| Demographic Characteristics | |||
| Age - Mean (SD) | 60.2 (13.3) | 55.9 (13.8) | 0.02 |
| Ethnicity - % | 0.67 | ||
| Hispanic | 8.5 | 8.6 | |
| Non-Hispanic Whites | 67.0 | 61.5 | |
| Non-Hispanic Blacks | 16.0 | 20.1 | |
| Other | 8.5 | 9.8 | |
| Education - % | 0.40 | ||
| 0:<=HS/GED | 20.2 | 25.7 | |
| 1:>HS | 79.8 | 74.3 | |
| Household Income - % | 0.86 | ||
| 1: <$20,000 | 24.7 | 23.9 | |
| 2: $20,000-$49,999 | 36.5 | 35.0 | |
| 3: $50,000-$79,999 | 23.5 | 22.1 | |
| 4: >=$80,000 | 15.3 | 19.0 | |
| Occupational Score - Mean (SD) | 61 (24.4) | 61.8 (23.5) | 0.61 |
| Baseline Incontinence Characteristics | |||
| Mesa Urge Score - Mean (SD) | 10.9 (3.3) | 11.3 (3.5) | 0.38 |
| Mesa Stress Score - Mean (SD) | 11.2 (6) | 10.7 (6.1) | 0.46 |
| Number of Incontinence Episodes per week on Bladder Diary - Mean (SD) | 3.5 (2.1) | 3.8 (2.5) | 0.27 |
| IIQ scores - Mean (SD) | 152.1 (90.4) | 150.4 (102.3) | 0.89 |
| OAB-q score - Mean (SD) | 62.3 (22.2) | 62.2 (24.4) | 0.97 |
| Duration of Incontinence - Mean (SD) | 9.6 (8.9) | 9.9 (11) | 0.83 |
| Prior Treatment/Surgery for Incontinence - % | 0.32 | ||
| Yes | 36.2 | 43.4 | |
| No | 63.8 | 56.6 | |
| Medical History and Physical Exam | |||
| Self assessment of Overall Health -% | 0.36 | ||
| 1: Excellent | 9.6 | 12.6 | |
| 2: Very Good | 36.1 | 34.8 | |
| 3: Good | 29.8 | 36.6 | |
| 4: Fair | 21.3 | 14.3 | |
| 5: Poor | 3.2 | 1.7 | |
| Fluid Intake - Mean (SD) | 62.9 (24.5) | 66.5 (29) | 0.24 |
| Current Estrogen Use - % | 0.18 | ||
| Post-menopausal on HRT | 17.0 | 17.1 | |
| Post-menopausal not on HRT | 56.4 | 45.1 | |
| Pre-menopausal | 26.6 | 37.7 | |
| Diabetes - % | 0.43 | ||
| Yes | 14.9 | 11.4 | |
| No | 85.1 | 88.6 | |
| Body Mass Index - Mean (SD) | 32.9 (7.1) | 32.9 (9.1) | 0.96 |
| POP-Q scores (Stage) - % | 0.99 | ||
| Stage 0/I | 61.7 | 60.9 | |
| Stage II | 35.1 | 36.2 | |
| Stage III/IV | 3.2 | 2.9 | |
| POPQ_AA - - Mean (SD) | -1.9 (1.1) | -1.9 (1.1) | 0.79 |
| POPQ_BA - - Mean (SD) | -1.8 (1.2) | -1.9 (1.1) | 0.59 |
| POPQ_Bp - - Mean (SD) | -2.2 (1) | -2.1 (1.1) | 0.27 |
| POPQ_C - - Mean (SD) | -6.7 (3) | -7.1 (2.8) | 0.32 |
| Pelvic floor muscle strength (Brinks) | 8.7 (1.8) | 8.9 (1.7) | 0.31 |
| Fecal Incontinence - % | 0.53 | ||
| Yes | 18.1 | 21.1 | |
| No | 81.9 | 78.9 | |
| SF-12 | |||
| PCS12 - Mean (SD) | 44.4 (12.5) | 45.1 (10.7) | 0.72 |
| MCS12 - Mean (SD) | 49.2 (9.7) | 48.3 (10.8) | 0.55 |
| HUI2 Overall - Mean (SD) | 0.8 (0.1) | 0.8 (0.2) | 0.62 |
Note: P-values are from logistic regression models including each covariate separately controlling for treatment group